問卷

TPIDB > Search Result

Search Result

篩選

List

2Cases

2024-01-01 - 2025-12-31

Phase IV

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
11Sites

Terminated11Sites

2026-07-01 - 2029-12-30

Phase III

Not yet recruiting
A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Master Protocol to Evaluate the Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus (Embold)
  • Condition/Disease

    Weight Management

  • Test Drug

    膜衣錠

Participate Sites
10Sites

Not yet recruiting10Sites